RLYB
Price:
$1.1
Market Cap:
$45.64M
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases...[Read more]
Industry
Biotechnology
IPO Date
2021-07-29
Stock Exchange
NASDAQ
Ticker
RLYB
According to Rallybio Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.62. This represents a change of -49.81% compared to the average of -1.24 of the last 4 quarters.
The mean historical PE Ratio of Rallybio Corporation over the last ten years is -10.97. The current -0.62 PE Ratio has changed 465.29% with respect to the historical average. Over the past ten years (40 quarters), RLYB's PE Ratio was at its highest in in the June 2024 quarter at -0.92. The PE Ratio was at its lowest in in the March 2020 quarter at -20.20.
Average
-10.97
Median
-6.52
Minimum
-25.70
Maximum
-1.30
Discovering the peaks and valleys of Rallybio Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -1.30
Minimum Annual Increase = -64.13%
Minimum Annual PE Ratio = -25.70
Year | PE Ratio | Change |
---|---|---|
2023 | -1.30 | -58.77% |
2022 | -3.14 | -51.77% |
2021 | -6.52 | -64.13% |
2020 | -18.18 | -29.28% |
The current PE Ratio of Rallybio Corporation (RLYB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.65
5-year avg
-10.97
10-year avg
-10.97
Rallybio Corporation’s PE Ratio is greater than Century Therapeutics, Inc. (-0.91), greater than Edgewise Therapeutics, Inc. (-14.14), greater than C4 Therapeutics, Inc. (-3.44), greater than Mineralys Therapeutics, Inc. (-4.63), greater than Cullinan Oncology, Inc. (-6.96), greater than Molecular Partners AG (-2.67), less than AN2 Therapeutics, Inc. (-0.47), greater than Pharvaris N.V. (-8.20), greater than PepGen Inc. (-3.22), greater than PMV Pharmaceuticals, Inc. (-1.58), greater than Opthea Limited (-1.11), greater than Third Harmonic Bio, Inc. (-26.95), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Eliem Therapeutics, Inc. (-3.49), greater than MediciNova, Inc. (-12.61),
Company | PE Ratio | Market cap |
---|---|---|
-0.91 | $123.69M | |
-14.14 | $1.64B | |
-3.44 | $374.42M | |
-4.63 | $558.43M | |
-6.96 | $1.04B | |
-2.67 | $182.90M | |
-0.47 | $30.44M | |
-8.20 | $1.03B | |
-3.22 | $287.77M | |
-1.58 | $77.28M | |
-1.11 | $444.73M | |
-26.95 | $493.17M | |
-3.11 | $349.21M | |
-3.49 | $495.57M | |
-12.61 | $103.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rallybio Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rallybio Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Rallybio Corporation's PE Ratio?
How is the PE Ratio calculated for Rallybio Corporation (RLYB)?
What is the highest PE Ratio for Rallybio Corporation (RLYB)?
What is the 3-year average PE Ratio for Rallybio Corporation (RLYB)?
What is the 5-year average PE Ratio for Rallybio Corporation (RLYB)?
How does the current PE Ratio for Rallybio Corporation (RLYB) compare to its historical average?